XML 18 R5.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Retained Deficit
Accumulated Other Comprehensive Income (Loss)
Total
Balance at beginning of period at Dec. 31, 2019 $ 233 $ 154,235 $ (49,731) $ (1,572) $ 103,165
Balance at beginning of period (in shares) at Dec. 31, 2019 23,335,855        
Increase (Decrease) in Stockholders' Equity          
Net loss     (13,196)   (13,196)
Unrealized income on foreign exchange rate translation       438  
Income tax expense       (66)  
Other comprehensive income       372 372
Issuance of common stock under stock compensation plans $ 3 (3)      
Issuance of common stock under stock compensation plans (in shares) 236,100        
Stock-based compensation expense   703     703
Shares exchanged for taxes on stock-based compensation $ (1) (69)     (70)
Shares exchanged for taxes on stock-based compensation (in shares) (45,438)        
Balance at end of period at Dec. 31, 2020 $ 235 154,866 (62,927) (1,200) $ 90,974
Balance at end of period (in shares) at Dec. 31, 2020 23,526,517       23,478,072
Increase (Decrease) in Stockholders' Equity          
Net loss     (29,091)   $ (29,091)
Unrealized income on foreign exchange rate translation       190  
Other comprehensive income       190 190
Issuance of common stock under stock compensation plans $ 2 (2)      
Issuance of common stock under stock compensation plans (in shares) 174,000        
Stock-based compensation expense   419     419
Issuance of common stock as compensation   60     60
Issuance of common stock as compensation (in shares) 23,272        
Shares exchanged for taxes on stock-based compensation   (75)     (75)
Shares exchanged for taxes on stock-based compensation (in shares) (31,410)        
Balance at end of period at Dec. 31, 2021 $ 237 $ 155,268 $ (92,018) $ (1,010) $ 62,477
Balance at end of period (in shares) at Dec. 31, 2021 23,692,379       23,643,934